HRT Financial’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-669,829
| Closed | -$964K | – | 2561 |
|
|
2025
Q1 | $964K | Buy |
669,829
+109,284
| +19% | +$157K | 0.01% | 963 |
|
|
2024
Q4 | $1.23M | Buy |
+560,545
| New | +$1.23M | 0.01% | 841 |
|
|
2024
Q2 | – | Sell |
-442,030
| Closed | -$1.18M | – | 2276 |
|
|
2024
Q1 | $1.18M | Buy |
442,030
+394,059
| +821% | +$1.06M | 0.01% | 776 |
|
|
2023
Q4 | $143K | Sell |
47,971
-18,799
| -28% | -$56K | ﹤0.01% | 1681 |
|
|
2023
Q3 | $65K | Sell |
66,770
-433,999
| -87% | -$422K | ﹤0.01% | 1766 |
|
|
2023
Q2 | $696K | Buy |
500,769
+481,346
| +2,478% | +$669K | 0.01% | 1081 |
|
|
2023
Q1 | $30K | Sell |
19,423
-433
| -2% | -$669 | ﹤0.01% | 1974 |
|
|
2022
Q4 | $123K | Sell |
19,856
-26,339
| -57% | -$163K | ﹤0.01% | 1844 |
|
|
2022
Q3 | $309K | Buy |
46,195
+12,729
| +38% | +$85.1K | ﹤0.01% | 1848 |
|
|
2022
Q2 | $212K | Buy |
+33,466
| New | +$212K | ﹤0.01% | 2154 |
|
|
2022
Q1 | – | Sell |
-235,475
| Closed | -$1.18M | – | 2998 |
|
|
2021
Q4 | $1.18M | Buy |
235,475
+50,791
| +28% | +$254K | 0.01% | 857 |
|
|
2021
Q3 | $2.23M | Buy |
+184,684
| New | +$2.23M | 0.01% | 599 |
|
|
2020
Q1 | – | Sell |
-6,825
| Closed | -$406K | – | 788 |
|
|
2019
Q4 | $406K | Buy |
+6,825
| New | +$406K | 0.02% | 563 |
|